biperiden has been researched along with Movement Disorders in 22 studies
Biperiden: A muscarinic antagonist that has effects in both the central and peripheral nervous systems. It has been used in the treatment of arteriosclerotic, idiopathic, and postencephalitic parkinsonism. It has also been used to alleviate extrapyramidal symptoms induced by phenothiazine derivatives and reserpine.
biperiden : A member of the class of piperidines that is N-propylpiperidine in which the methyl hydrogens have been replaced by hydroxy, phenyl, and 5-norbornen-2-yl groups. A muscarinic antagonist affecting both the central and peripheral nervous systems, it is used in the treatment of all forms of Parkinson's disease.
Movement Disorders: Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.
| Excerpt | Relevance | Reference |
|---|---|---|
| " SCH 23390 (a selective D1 antagonist) and raclopride (a selective D2 antagonist) induced identical syndromes consisting of dystonia and oral dyskinesia." | 3.67 | Selective D1 and D2 receptor manipulation in Cebus monkeys: relevance for dystonia and dyskinesia in humans. ( Gerlach, J; Kistrup, K, 1987) |
| "She had a cavernous angioma (CA) of left thalamo-mesencephalic junction, revealed by magnetic resonance imaging (MRI)." | 2.40 | Cavernous angioma presenting with hemidystonia. ( Akbostanci, MC; Ulkatan, S; Yiğit, A, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 18 (81.82) | 18.7374 |
| 1990's | 2 (9.09) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Niederhofer, H | 1 |
| Fonseca, L | 1 |
| Rodrigues, M | 1 |
| Machado, A | 1 |
| ALLEVA, PM | 1 |
| Salokangas, RK | 1 |
| Syvälahti, E | 1 |
| Lehtinen, I | 1 |
| König, P | 1 |
| Chwatal, K | 1 |
| Havelec, L | 1 |
| Riedl, F | 1 |
| Schubert, H | 1 |
| Schultes, H | 1 |
| Akbostanci, MC | 1 |
| Yiğit, A | 1 |
| Ulkatan, S | 1 |
| Gerlach, J | 3 |
| Thorsen, K | 1 |
| Kistrup, K | 1 |
| Mano, T | 1 |
| Birket-Smith, E | 1 |
| Weller, E | 1 |
| ten Bruggencate, HG | 1 |
| Jurna, I | 4 |
| Lanzer, G | 1 |
| Theres, C | 1 |
| Bachmann, T | 1 |
| Klett, CJ | 1 |
| Caffey, E | 1 |
| Simpson, GM | 1 |
| Beckles, D | 1 |
| Isalski, Z | 1 |
| Lee, JH | 1 |
| Reisby, N | 1 |
| Randrup, A | 1 |
| Ayd, FJ | 1 |
| Witzel, K | 1 |
| Bellabarba, U | 1 |
| Hippius, H | 1 |
| Kanowski, S | 1 |
| Meyer, HH | 1 |
2 reviews available for biperiden and Movement Disorders
| Article | Year |
|---|---|
Cavernous angioma presenting with hemidystonia.
Topics: Adult; Antiparkinson Agents; Biperiden; Brain Neoplasms; Female; Hemangioma, Cavernous; Humans; Magn | 1998 |
Side effects of depot fluphenazines.
Topics: Agranulocytosis; Barbiturates; Basal Ganglia Diseases; Benztropine; Biperiden; Delayed-Action Prepar | 1974 |
5 trials available for biperiden and Movement Disorders
| Article | Year |
|---|---|
Amantadine versus biperiden: a double-blind study of treatment efficacy in neuroleptic extrapyramidal movement disorders.
Topics: Amantadine; Biperiden; Double-Blind Method; Female; Humans; Male; Movement Disorders; Schizophrenia; | 1996 |
The movement pattern of oral tardive dyskinesia in relation to anticholinergic and antidopaminergic treatment.
Topics: Adult; Aged; Biperiden; Cheek; Clinical Trials as Topic; Humans; Methyltyrosines; Middle Aged; Mouth | 1976 |
Evaluating the long-term need for antiparkinson drugs by chronic schizophrenics.
Topics: 1-Propanol; Adult; Antiparkinson Agents; Basal Ganglia Diseases; Benztropine; Biperiden; Chronic Dis | 1972 |
Some methodological considerations in the evaluation of drug-induced extrapyramidal disorders: a study of Ex10-029, a new morphanthridine derivative.
Topics: Adult; Antiparkinson Agents; Basal Ganglia Diseases; Biperiden; Chronic Disease; Clinical Trials as | 1972 |
Dopaminergic hypersensitivity and cholinergic hypofunction in the pathophysiology of tardive dyskinesia.
Topics: Adult; Age Factors; Aged; Biperiden; Clinical Trials as Topic; Dihydroxyphenylalanine; Dopamine; Fem | 1974 |
15 other studies available for biperiden and Movement Disorders
| Article | Year |
|---|---|
Tizanidine is not effective treating EPMS.
Topics: Adolescent; Adult; Basal Ganglia Diseases; Biperiden; Cholinergic Antagonists; Clonidine; Clopenthix | 2018 |
Psychogenic movement disorder after a venlafaxine-induced dystonia.
Topics: Adult; Antiparkinson Agents; Biperiden; Cyclohexanols; Dystonia; Female; Humans; Movement Disorders; | 2010 |
[AKINETON IN PARKINSONISM CAUSED BY DRUGS].
Topics: Anti-Allergic Agents; Biperiden; Haloperidol; Histamine H1 Antagonists; Movement Disorders; Neurolog | 1963 |
Dyskinesia and eye tracking dysfunction in young schizophrenic patients - a pilot study.
Topics: Adolescent; Adult; Antiparkinson Agents; Antipsychotic Agents; Biperiden; Eye Movements; Female; Hum | 1983 |
Selective D1 and D2 receptor manipulation in Cebus monkeys: relevance for dystonia and dyskinesia in humans.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antipsychotic Agents; Benzazepi | 1987 |
[Dyskinesia induced by anticholinergic drugs--electrophysiological analysis].
Topics: Aged; Benztropine; Biperiden; Electromyography; Female; Humans; Male; Middle Aged; Movement Disorder | 1974 |
Abnormal involuntary movements induced by anticholinergic therapy.
Topics: Aged; Biperiden; Dibenzazepines; Female; Humans; Mastication; Middle Aged; Movement Disorders; Orphe | 1974 |
[Effects of antiparkinsonian drugs on curare-induced tremor in cats].
Topics: Action Potentials; Animals; Biperiden; Cats; Cerebral Ventricles; Electromyography; Laminectomy; Mot | 1968 |
Reserpine rigidity in the rat--a model for the analysis of antiparkinson drugs.
Topics: 1-Propanol; Animals; Biperiden; Cerebral Decortication; Electromyography; Methamphetamine; Models, N | 1968 |
Depression by antiparkinson drugs of reserpine rigidity.
Topics: 1-Propanol; Animals; Biperiden; Cyclohexanes; Depression, Chemical; Electromyography; Methamphetamin | 1968 |
Inhibition of the effect of reserpine on motor control by drugs which influence reserpine rigidity.
Topics: 1-Propanol; Animals; Atropine; Biperiden; Cyclohexanes; Cyclopentanes; Depression, Chemical; Dihydro | 1969 |
The effect of physostigmine and tetrabenazine on spinal motor control and its inhibition by drugs which influence reserpine rigidity.
Topics: 1-Propanol; Animals; Atropine; Biperiden; Dihydroxyphenylalanine; Electric Stimulation; Electromyogr | 1969 |
[Paspertin (Metoclopramide) as a cause of dystonic-hyperkinetic syndromes in children].
Topics: Amides; Benzoates; Biperiden; Child; Diazepam; Female; Gastrointestinal Diseases; Humans; Hyperkines | 1972 |
[On the differential diagnosis of hyperkinetic, dystonic side effects of psychopharmaca].
Topics: Adult; Biperiden; Diagnosis, Differential; Drug Antagonism; Female; Humans; Male; Middle Aged; Movem | 1967 |
[On the question of possible irreversible disorders due to psychopharmacotherapy].
Topics: Adult; Autonomic Nervous System; Biperiden; Butyrophenones; Central Nervous System; Chlorpromazine; | 1966 |